FOXBOROUGH, Mass.--(BUSINESS WIRE)--Cyberkinetics Neurotechnology Systems, Inc. (OTCBB: CYKN; Cyberkinetics), a medical device company focused on developing novel implantable products to treat neurological diseases and injuries of the central nervous system, announced that the United States Patent and Trademark Office recently issued U.S. patent 7,212,851, entitled “Microstructured Arrays for Cortex Interaction and Related Methods of Manufacture and Use,” to Brown University and the Massachusetts Institute of Technology. Cyberkinetics is the exclusive licensee of the patent, which relates to the next generation of Cyberkinetics’ BrainGate neural interface technology.
